Combined Therapeutics Wins $250,000 MilliporeSigma Advance Biotech Grant

MilliporeSigma has awarded MIT spin-out Combined Therapeutics a check for $250,000 as the winner of its 2020 Advance Biotech Grant.

Combined Therapeutics (CTx) is an early stage startup developing the second generation of therapeutic and intelligent messenger RNA (mRNA).